7 studies on AMPK mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This comprehensive review underscores the immense potential of novel drug targets, innovative drug classes, and cutting-edge technologies to revolutionize the treatment landscape for metabolic diseases. The insights g…
If successful, this trial could identify a novel dietary supplement, AMPK Charge+®, that effectively improves glycemic control in individuals with prediabetes or Type 2 Diabetes. The potential for AMPK Charge+® to enh…
This study reveals a specific, localized gut-brain-liver axis where intestinal ghrelin acts as a negative regulator of glucose metabolism. For individuals monitoring metabolic health, this suggests that the timing and…
This study identifies UAG(6-13) as a potent, novel therapeutic agent for protecting the heart from ischemia-reperfusion injury. For researchers and clinicians, this finding opens a new avenue for developing treatments…
This study identifies ghrelin as a potent neuroprotective agent in a preclinical model of neonatal brain injury, operating through a clearly defined signaling pathway that combats oxidative stress and cell death. For …
The finding that Melanotan II and other synthetic agonists produce a much longer-lasting signal than the body's natural ligand, α-MSH, has significant implications for dosing and expected effects. This 'temporal signa…
This research provides a novel mechanistic understanding of how endurance training improves skeletal muscle mitochondrial function, highlighting MOTS-c as a key player. The findings suggest that circulating MOTS-c lev…